SANUWAVE Health, Inc. (SNWV)
NASDAQ: SNWV · Real-Time Price · USD
35.61
-0.95 (-2.59%)
Mar 31, 2025, 3:28 PM EDT - Market open
SANUWAVE Health Revenue
In the year 2024, SANUWAVE Health had annual revenue of $32.63M with 59.99% growth. SANUWAVE Health had revenue of $10.33M in the quarter ending December 31, 2024, with 47.64% growth.
Revenue (ttm)
$32.63M
Revenue Growth
+59.99%
P/S Ratio
5.00
Revenue / Employee
$709,435
Employees
46
Market Cap
304.37M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 32.63M | 12.24M | 59.99% |
| Dec 31, 2023 | 20.40M | 3.66M | 21.84% |
| Dec 31, 2022 | 16.74M | 3.73M | 28.69% |
| Dec 31, 2021 | 13.01M | 8.95M | 220.68% |
| Dec 31, 2020 | 4.06M | 3.03M | 294.37% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 400.28B |
| Johnson & Johnson | 88.82B |
| Merck & Co. | 64.17B |
| AbbVie | 56.33B |
| AstraZeneca | 54.07B |
| Novartis AG | 51.72B |
| Eli Lilly and Company | 45.04B |
| Thermo Fisher Scientific | 42.88B |
SNWV News
- 10 days ago - SANUWAVE Health, Inc. (SNWV) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 10 days ago - SANUWAVE Announces Record Quarterly Revenues: Q4 FY2024 Financial Results - GlobeNewsWire
- 14 days ago - SANUWAVE Will Host a Conference Call on March 21, 2025 at 8:30 AM (ET) to Present Q4 and Full Year 2024 Financial Results - Business Wire
- 26 days ago - Sanuwave Health to Uplist to the Nasdaq Global Market - GlobeNewsWire
- 5 weeks ago - SANUWAVE Health to Participate in 37th Annual Roth Conference - GlobeNewsWire
- 5 months ago - SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results - GlobeNewsWire
- 5 months ago - SANUWAVE Will Host a Conference Call on November 8, 2024 at 8:30 AM (ET) to Present Q3 Financial Results - GlobeNewsWire
- 5 months ago - SANUWAVE Health Announces 1-For-375 Reverse Stock Split - GlobeNewsWire